← FDA DRUG APPROVALS

FDA ANDA · ANDA202392

RAMIPRIL

Sponsor: ACCORD HLTHCARE

APPLICATION
ANDA202392
TYPE
ANDA
ORIGINAL APPROVAL
2014-04-15
LATEST ACTION
2018-11-19
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

RAMIPRILDiscontinued
RAMIPRIL 5MG · CAPSULE · ORAL
RAMIPRILDiscontinued
RAMIPRIL 1.25MG · CAPSULE · ORAL
RAMIPRILDiscontinued
RAMIPRIL 10MG · CAPSULE · ORAL
RAMIPRILDiscontinued
RAMIPRIL 2.5MG · CAPSULE · ORAL

Approval history

2018-11-19Labeling · Supplement 2 · standardAP
2018-11-19Labeling · Supplement 3 · standardAP
2015-01-07Labeling · Supplement 1 · standardAP
2014-04-15UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →